| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ | Director | Stock Option (Right to Buy) | 227,272 | $249,999 | $1.10 | 08 Nov 2025 | Direct |
| HERON THERAPEUTICS, INC. /DE/ | Director | Common Stock | 53,960 | $70,148 | $1.30 | 30 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 30 Jan 2026 | 1 | $0 | 4 | Director | 03 Feb 2026, 10:00 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 08 Nov 2025 | 2 | +$249,999 | 4 | Director | 12 Nov 2025, 09:20 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 27 Oct 2025 | 0 | $0 | 3 | Director | 07 Nov 2025, 09:30 |